Perfil
Dale E.
Johnson is the founder of Emiliem, Inc. He previously worked as the Vice President-Drug Assessment & Development at Chiron Corp.
He holds a doctorate degree from the University of Michigan and an undergraduate degree from the University of Michigan College of Pharmacy.
Cargos activos de Dale E. Johnson
| Empresas | Cargo | Inicio |
|---|---|---|
Emiliem, Inc.
 Emiliem, Inc. BiotechnologyHealth Technology Emiliem, Inc. develops drugs for the treatment of cancer. The firm is particularly interested in diagnostic markers for rare diseases and the computational aspects of predicting both positive and negative patient outcomes. The company was founded by James E. Burden and Sucha Sudarsanam in 2005 and is headquartered in Berkeley, CA. | Fundador | - |
Antiguos cargos conocidos de Dale E. Johnson.
| Empresas | Cargo | Fin |
|---|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
Formación de Dale E. Johnson.
| University of Michigan | Doctorate Degree |
| University of Michigan College of Pharmacy | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Emiliem, Inc.
Emiliem, Inc. BiotechnologyHealth Technology Emiliem, Inc. develops drugs for the treatment of cancer. The firm is particularly interested in diagnostic markers for rare diseases and the computational aspects of predicting both positive and negative patient outcomes. The company was founded by James E. Burden and Sucha Sudarsanam in 2005 and is headquartered in Berkeley, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Dale E. Johnson
